DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Election/Restrictions
Claims 22-31 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected Invention II, there being no allowable generic or linking claim. Election was made without traverse in the response filed on 25 May 2026 of Invention I, directed to Claims 12-21.
Specification
The disclosure is objected to because of the following informalities:
Since this application is a DIV of Application No. 16/300,361, now U.S. Patent No. 12,029,896, the Specification should have a first paragraph stating details of the parent application.
Appropriate correction is required.
Claim Objections
Claim 16 is objected to because of the following informalities: Claim 16 recites “said medical thread” in Line 3. This should be amended to “said medical thread structure” to maintain consistency for this term in the claims. Appropriate correction is required.
Claim Rejections - 35 USC § 102
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claims 12-19 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Williams ‘911 (US Publication No. 2014/0031911).
Regarding Claim 12, 13, and 14, Williams ‘911 discloses a medical thread structure, comprising:
a plurality of filaments (56, 58, Figs. 3-4, 6, 7; 82, 84, 86, 88, Figs. 5; Paragraph 0034, 0038, 0047, 0053, Claim 1) interlocked so as to form an interlocked thread electrode lead (50, Figs. 3A-B; 70, Figs. 4A-B; 80, Figs. 5A-B; 90, Figs. 6A-B; 95, Figs. 7A-B; Paragraph 0005, 0024, 0027, 0030) having distal and proximal ends, wherein at least one of said plurality of filaments has a conductive core (64, Figs. 3-7; Paragraph 0034, 0036, 0038, 0047, 0053, Claim 1) exposed at a first location along a longitudinal extent of said interlocked thread (exposed sections allows for connections between electrodes 30, 32, 34, 36, 38, 40, 42, 44; Fig. 2, Paragraph 0027-0031), wherein said conductive core exposed at said first location serves as an electrode contact (connections at distal end to electrodes 30, 32, 34, 36, 38, 40, 42, 44; Fig. 2; Paragraph 0027-0031; Claims 13-14), and wherein at least one conductor connects a connection terminal to said electrode contact (“each of the electrodes 30, 32, 34, 36, 38, 40, 42 and 44 is electrically coupled to a respective conductor within its associated lead bodies…The respective conductors may couple to circuitry, such as a therapy module or a sensing module, of IMD 22 via connections in connector block 32 and one or more feedthroughs (not shown). The electrical conductors transmit therapy from the therapy module within IMD 22 to one or more electrodes 30, 32, 34, 36, 38, 40, 42 and 44 and transmit sensed electrical signals from one or more electrodes 38, 40, 42 and 44 to the sensing module within IMD 22. The conductors within leads 24, 26, and 28 may be coiled conductors also have a conductive core and, in some instances, an insulation layer surrounding the conductive core”, Paragraph 0030);
and wherein said at least one of said plurality of filaments has the conductive core exposed at a second location (connections at proximal end to contacts in connection block 32, Fig. 2) along said longitudinal extent of said interlocked thread, wherein said exposed core at said second location serves as a connection terminal (contacts at proximal end in connector block 32/feedthrough, Fig. 2; “The respective conductors may couple to circuitry, such as a therapy module or a sensing module, of IMD 22 via connections in connector block 32 and one or more feedthroughs (not shown). The electrical conductors transmit therapy from the therapy module within IMD 22 to one or more electrodes 30, 32, 34, 36, 38, 40, 42 and 44 and transmit sensed electrical signals from one or more electrodes 38, 40, 42 and 44 to the sensing module within IMD 22. The conductors within leads 24, 26, and 28 may be coiled conductors also have a conductive core and, in some instances, an insulation layer surrounding the conductive core”, Paragraph 0030”);
and wherein a functional material (insulation 52, 66, Figs. 3-7; Paragraph 0028, 0036-0038, 0040, 0042, 0045, 0054) at least partially incorporated between said plurality of filaments (56, 58, Figs. 3-4, 6, 7; 82, 84, 86, 88, Figs. 5; Paragraph 0034, 0038, 0047, 0053, Claim 1), wherein said functional material (52, 66, Figs. 3-7) is configured to form insulation areas within said interlocked thread electrode lead (within body and between threads, Paragraph 0028, 0036-0038, 0042, 0045, 0054), and
wherein said functional material is configured to insulate said at least portion of said interlocked thread electrode lead upon application of heat onto said interlocked thread electrode lead (heating to cause reflow to form insulative jacket, Paragraph 0007, 0045, 0054; 106, Fig. 8), thus causing melting of said functional material into a single continuous structure (lead body total structure, 50, Figs. 3A-B; 70, Figs. 4A-B; 80, Figs. 5A-B; 90, Figs. 6A-B; 95, Figs. 7A-B; Paragraph 0005, 0024, 0027, 0030, 0055).
Regarding Claim 15, Williams ‘911 discloses a medical thread structure further wherein at least one filament of said plurality of filaments (56, 58, Figs. 3-4, 6, 7; 82, 84, 86, 88, Figs. 5; Paragraph 0034, 0038, 0047, 0053, Claim 1) has a portion that is a coil (Abstract, Paragraph 0005-0006, 0034-0035; 102, Fig. 8).
Regarding Claim 16, Williams ‘911 discloses a medical thread structure further wherein at least one filament of said plurality of filaments (56, 58, Figs. 3-4, 6, 7; 82, 84, 86, 88, Figs. 5; Paragraph 0034, 0038, 0047, 0053, Claim 1) has a portion that is made of a plurality of loops arranged in patterns (coil/loop patterns, Abstract, Paragraph 0005-0006, 0034-0035; 102, Fig. 8) which are configured to allow expansion of said medical thread (allows for expansion/reflow, Paragraph 0007, 0045, 0054; 106, Fig. 8; allowing for flexibility of lead due to coils, Paragraph 0046, 0047, 0052, 0054).
Regarding Claim 17, Williams ‘911 discloses a medical thread structure further wherein said plurality of filaments (56, 58, Figs. 3-4, 6, 7; 82, 84, 86, 88, Figs. 5; Paragraph 0034, 0038, 0047, 0053, Claim 1) are arranged in layers (multiple layers, Paragraph 0030, 0034, 0036-0038, 0042, 0045) and said connection terminal is disposed on an inner layer (contacts at proximal end in connector block 32/feedthrough, Fig. 2; located within connector block 32/feedthrough as shown in Fig. 2 which are connected to filaments [i.e. “inner layer”]; Paragraph 0030).
Regarding Claim 18, Williams ‘911 discloses a medical thread structure further comprising a bulk of functional material (insulation 52, 66, Figs. 3-7; Paragraph 0028, 0036-0038, 0040, 0042, 0045, 0054) integrally incorporated between at least part of said plurality of filaments (56, 58, Figs. 3-4, 6, 7; 82, 84, 86, 88, Figs. 5; Paragraph 0034, 0038, 0047, 0053, Claim 1), or a tube or jacket of functional material (insulation 52, 66, Figs. 3-7; Paragraph 0028, 0036-0038, 0040, 0042, 0045, 0054) placed around said plurality of filaments (56, 58, Figs. 3-4, 6, 7; 82, 84, 86, 88, Figs. 5; Paragraph 0034, 0038, 0047, 0053, Claim 1);
wherein said functional material is configured to fill gaps in said interlocked thread electrode lead (insulation 52, 66, Figs. 3-7; Paragraph 0028, 0036-0038, 0040, 0042, 0045, 0054) and form a barrier that prevents any pressure or fluidic leakages between distal and proximal sides of the barrier (prevents air/fluid leakage to maintain dielectric/biocompatibility functionality, Paragraph 0040, 0042-0046), and
wherein said functional material is configured to form said barrier upon application of heat onto said interlocked thread electrode lead (heating to cause reflow to form insulative jacket, Paragraph 0007, 0045, 0054; 106, Fig. 8), thus causing melting of said functional material (Paragraph 0007, 0045, 0054; 106, Fig. 8).
Regarding Claim 19, Williams ‘911 discloses a medical thread structure further comprising an inner tube disposed inside (54, Figs. 3-5) said interlocked thread electrode lead (Paragraph 0032, 0034, 0040, 0044-0046).
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
Claims 20 and 21 are rejected under 35 U.S.C. 103 as being unpatentable over Williams ‘911 (US Publication No. 2014/0031911) in view of Willaims ‘600 (US Publication No. 2004/0162600).
Regarding Claim 20, Williams ‘911 discloses a medical thread structure further wherein the conductive core (64, Figs. 3-7; Paragraph 0034, 0036, 0038, 0047, 0053, Claim 1) is exposed at a first location along a longitudinal extent of said interlocked thread (exposed sections allows for connections between electrodes 30, 32, 34, 36, 38, 40, 42, 44; Fig. 2, Paragraph 0027-0031) or is exposed at a second location along a longitudinal extent of said interlocked thread (connections at proximal end to contacts in connection block 32, Fig. 2), but does not explicitly disclose wherein said conductive core is exposed on a circumferential surface of the interlocked thread electrode lead.
Williams ‘600 teaches a medical thread structure comprising a plurality of filaments (51, 52, Fig. 1A; 61, 62, Fig. 1B; 71, 72, 73, 74, Fig. 1C; Paragraph 0014-0016, 0021) with a conductive core (“formed from any material capable of reliably conducting electrical current after having been subjected to numerous repetitive bending and torsional stresses, examples of such materials include tantalum, MP35-N alloy, platinum, Elgiloy, and stainless steel”, Paragraph 0014) configured to form an interlocked thread electrode lead (Abstract; Claim 1; Paragraph 0001), wherein said conductive core is exposed on a circumferential surface of the interlocked thread electrode lead to form an electrode/contact (91-94, 76-78, Fig. 1C, 4; Paragraph 0020; see also Paragraphs 0014-0016 which discuss exposed core electrodes 53, 64, Figs. 1A-B).
It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to configure the conductive core in the medical thread structure disclosed by Williams ‘911 to be exposed on a circumferential surface of the interlocked thread electrode lead as taught by Williams ‘600, so as to “[eliminate] as many joints as is practical in the construction of a lead [which] may improve the reliability of the lead and increase the ease of manufacturing” (Williams ‘600, Paragraph 0003) in order to provide stimulation and/or sense signals from tissue. Furthermore, exposing the conductive core on a circumferential surface would merely involve relocating the exposed section, and it has been held that rearranging parts of an invention involves only routine skill in the art. In re Japikse, 86 USPQ 70.
Regarding Claim 21, Williams ‘911 discloses a medical thread structure further wherein said plurality of filaments (56, 58, Figs. 3-4, 6, 7; 82, 84, 86, 88, Figs. 5; Paragraph 0034, 0038, 0047, 0053, Claim 1) within the interlocked thread electrode lead have both vertical portions and horizontal portions (both horizontal and vertical portions, see 6, 58, Figs. 3-4, 6, 7; 82, 84, 86, 88, Figs. 5), and lock therewith (Paragraph 0005, 0024, 0027, 0030; Claim 1). However Williams ‘911 does not explicitly disclose a horizontal portion of a filament is configured to pass between vertical portions of other filaments and lock therewith.
Williams ‘600 teaches a medical thread structure comprising a plurality of filaments (51, 52, Fig. 1A; 61, 62, Fig. 1B; 71, 72, 73, 74, Fig. 1C; Paragraph 0014-0016, 0021) wherein a horizontal portion of a filament is configured to pass between vertical portions of other filaments and lock therewith (reverse winding of vertical/horizontal conductor filaments, 51, 52, Fig. 1A; 61, 62, Fig. 1B; 71, 72, 73, 74, Fig. 1C; Paragraph 0014-0020, 0023; Claim 1, 11-13).
It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to configure the plurality of filaments in the medical thread structure disclosed by Williams ‘911 to have a horizontal portion of a filament is configured to pass between vertical portions of other filaments and lock therewith, as taught by Williams ‘600, so as to “[eliminate] as many joints as is practical in the construction of a lead [which] may improve the reliability of the lead and increase the ease of manufacturing” (Williams ‘600, Paragraph 0003) in order to provide stimulation and/or sense signals from tissue. Furthermore, such a modification would have involved a mere change in the form or shape of a component. A change in form or shape is generally recognized as being within the level of ordinary skill in the art. In re Dailey, 149 USPQ 47 (CCPA 1976).
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to PAMELA M BAYS whose telephone number is (571)270-7852. The examiner can normally be reached 10:00am - 6:00pm EST.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer McDonald can be reached at 571-270-3061. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free).
If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/PAMELA M. BAYS/ Primary Examiner, Art Unit 3796